Vaughan Nelson Investment Management, L.P. Moderna, Inc. Transaction History

Vaughan Nelson Investment Management, L.P.

  • $11.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 13, 2022
SELL
$225.82 - $368.51 $51.6 Million - $84.2 Million
-228,430 Closed
0 $0
Q3 2021

Oct 27, 2021
SELL
$221.9 - $484.47 $160 Million - $350 Million
-721,953 Reduced 75.96%
228,430 $87.9 Million
Q2 2021

Jul 15, 2021
BUY
$129.91 - $234.98 $123 Million - $223 Million
950,383 New
950,383 $223 Million

Others Institutions Holding MRNA

# of Institutions
954
Shares Held
241M
Call Options Held
10.6M
Put Options Held
18.7M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Vaughan Nelson Investment Management, L.P. Portfolio

Follow Vaughan Nelson Investment Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan Nelson Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Vaughan Nelson Investment Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email